Hospira Tells Fed. Circ. To Reverse Sedative Patent Loss

Hospira Inc. asked the Federal Circuit on Tuesday to uphold the validity of a patent for its sedation drug Precedex for the second time this year, arguing that an Illinois federal court hadn’t correctly analyzed the obviousness of a key claim when deciding to invalidate the patent…

Read this piece in its entirety at Law360.

Comments

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s